_version_ 1783719323547729920
author Gay, Cynthia L.
Bosch, Ronald J.
McKhann, Ashley
Moseley, Kendall F.
Wimbish, Chanelle L.
Hendrickx, Steven M.
Messer, Michael
Furlong, Maureen
Campbell, Danielle M.
Jennings, Cheryl
Benson, Constance
Overton, Edgar T.
Macatangay, Bernard J. C.
Kuritzkes, Daniel R.
Miller, Elizabeth
Tressler, Randall
Eron, Joseph J.
Hardy, William David
author_facet Gay, Cynthia L.
Bosch, Ronald J.
McKhann, Ashley
Moseley, Kendall F.
Wimbish, Chanelle L.
Hendrickx, Steven M.
Messer, Michael
Furlong, Maureen
Campbell, Danielle M.
Jennings, Cheryl
Benson, Constance
Overton, Edgar T.
Macatangay, Bernard J. C.
Kuritzkes, Daniel R.
Miller, Elizabeth
Tressler, Randall
Eron, Joseph J.
Hardy, William David
author_sort Gay, Cynthia L.
collection PubMed
description
format Online
Article
Text
id pubmed-8263135
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-82631352021-07-08 Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV Gay, Cynthia L. Bosch, Ronald J. McKhann, Ashley Moseley, Kendall F. Wimbish, Chanelle L. Hendrickx, Steven M. Messer, Michael Furlong, Maureen Campbell, Danielle M. Jennings, Cheryl Benson, Constance Overton, Edgar T. Macatangay, Bernard J. C. Kuritzkes, Daniel R. Miller, Elizabeth Tressler, Randall Eron, Joseph J. Hardy, William David J Acquir Immune Defic Syndr Letters to the Editor JAIDS Journal of Acquired Immune Deficiency Syndromes 2021-08-15 2021-05-01 /pmc/articles/PMC8263135/ /pubmed/33929394 http://dx.doi.org/10.1097/QAI.0000000000002716 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Gay, Cynthia L.
Bosch, Ronald J.
McKhann, Ashley
Moseley, Kendall F.
Wimbish, Chanelle L.
Hendrickx, Steven M.
Messer, Michael
Furlong, Maureen
Campbell, Danielle M.
Jennings, Cheryl
Benson, Constance
Overton, Edgar T.
Macatangay, Bernard J. C.
Kuritzkes, Daniel R.
Miller, Elizabeth
Tressler, Randall
Eron, Joseph J.
Hardy, William David
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
title Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
title_full Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
title_fullStr Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
title_full_unstemmed Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
title_short Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
title_sort suspected immune-related adverse events with an anti-pd-1 inhibitor in otherwise healthy people with hiv
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263135/
https://www.ncbi.nlm.nih.gov/pubmed/33929394
http://dx.doi.org/10.1097/QAI.0000000000002716
work_keys_str_mv AT gaycynthial suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT boschronaldj suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT mckhannashley suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT moseleykendallf suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT wimbishchanellel suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT hendrickxstevenm suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT messermichael suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT furlongmaureen suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT campbelldaniellem suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT jenningscheryl suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT bensonconstance suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT overtonedgart suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT macatangaybernardjc suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT kuritzkesdanielr suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT millerelizabeth suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT tresslerrandall suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT eronjosephj suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv
AT hardywilliamdavid suspectedimmunerelatedadverseeventswithanantipd1inhibitorinotherwisehealthypeoplewithhiv